Melatonin: Neurobiological background and neuropsychiatric application in children;Melatonine: Neurobiologische achtergronden en neuropsychiatrische toepassing bij kinderen

Tijdschrift voor Psychiatrie

Volumn 48, Issue 2, 2006, Pages 107-117

  Debruyne, C ^a,b,c  

^a UPC Sint Kamillus   (Belgium)

^b Openbaar Psychiatrisch Ziekenhuis   (Belgium)

^c Flemish Community   (Belgium)

Author keywords

Adolescent; Child; Melatonin; Therapeutic use

Indexed keywords

ANTICONVULSIVE AGENT; ANTIOXIDANT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; MELATONIN; NEUROHORMONE;

DRUG EFFICACY; DRUG SAFETY; MEDICAL LITERATURE; MEDICAL RESEARCH; MOOD DISORDER; PINEAL BODY; PUBERTY; REVIEW; SEIZURE;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD DEVELOPMENT; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; HUMANS; MELATONIN; PINEAL GLAND; PUBERTY; SLEEP;

EID: 33244458208     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Attanasio, A., Borrelli, P., & Gupta, D. (1985). Circadian rhythms in serum melatonin from infancy to adolescence. The Journal of Clinical Endocrinology and Metabolism, 61, 388-390.
2. Avery, D., Lenz, M., & Landis, C. (1998). Guidelines for prescribing melatonin. Annals of Medicine, 30, 122-130.
3. Balentine, J., & Hagman, J. (1997). More on melatonin. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1013.
4. Camfield, P., Gordon, K., Dooley, J., e.a. (1996). Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: 'N of 1' trials. Journal of Child Neurology, 11, 341-343.
5. Cavallo, A., Holt, K.G., Hejazi, M.S., e.a. (1987). Melatonin circadian rhythm in childhood depression. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 395-399.
6. Dodge, N.N., & Wilson, G.A. (2001). Melatonin for treatment of sleep disorders in children with developmental disabilities. Journal of Child Neurology, 16, 581-584.
7. Griefahn, B., Bröde, P., Blaszkewicz, M., e.a. (2003). Melatonin production during childhood and adolescence: a longitudinal study on the excretion of urinary 6-hydroxymelatonin sulfate. Journal of Pineal Research, 34, 26-31.
8. Guardiola-Lemaître, B. (1997). Toxicology of melatonin. Journal of Biological Rhythms, 12, 697-706.
9. Gupta, M., Aneja, S., & Kohli, K. (2004). Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial. Epilepsy & Behavior, 5, 316-321.
10. Gupta, M., Gupta, Y.K., Agarwal, S., e.a. (2004). A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes. British Journal of Clinical Pharmacology, 58, 542-547.
11. Hung, J.C.C., Appleton, R.E., Nunn, A.J., e.a. (1998). The use of melatonin in the treatment of sleep disturbances in children with neurological or behavioural disorders. The Journal of Pediatric Pharmacy Practice, 3, 250-256.
12. Ivanenko, A., Crabtree, V.M., Tauman, R., e.a. (2003). Melatonin in children and adolescents with insomnia: a retrospective study. Clinical Pediatrics, 42, 51-58.
13. Jan, J.E., Connolly, M.B., Hamilton, D., e.a. (1999). Melatonin treatment of non-epileptic myoclonus in children. Developmental Medicine and Child Neurology, 41, 255-259.
14. Jan, J.E., & Espezel, H. (1995). Melatonin treatment of chronic sleep disorders. Developmental Medicine and Child Neurology, 37, 279-280.
15. Jan, J.E., Espezel, H., & Appleton, R.E. (1994). The treatment of sleep disorders with melatonin. Developmental Medicine and Child Neurology, 36, 97-107.
16. Jan, J.E., & Freeman, R.D. (2004). Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Developmental Medicine and Child Neurology, 46, 776-782.
17. Jan, J.E., Freeman, R.D., & Fast, D.K. (1999). Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Developmental Medicine and Child Neurology, 41, 491-500.
18. Lewy, A.J., Ahmed, S., Jackson, J.M., e.a. (1992). Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiology International, 9, 380-392.
19. Maurizi, C.P. (1997). Could exogenous melatonin prevent sudden infant death syndrome? Medical Hypotheses, 49, 425-427.
20. McArthur, A.J., & Budden, S.S. (1998). Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Developmental Medicine and Child Neurology, 40, 186-192.
21. Miles, A., & Philbrick, D.R. (1988). Melatonin and psychiatry. Biological Psychiatry, 23, 405-425.
22. Nagtegaal, E., Peeters, T., Swart, W., e.a. (1998). Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Therapeutic Drug Monitoring, 20, 181-183.
23. Palm, L., Blennow, G., & Wetterberg, L. (1997). Long-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances. Developmental Medicine and Child Neurology, 39, 319-325.
24. Phillips, L., & Appleton, R.E. (2004). Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Developmental Medicine and Child Neurology, 46, 771-775.
25. Ray, M., Mediratta, P.K., Reeta, Kh., e.a. (2004). Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures. Methods and Findings in Experimental and Clinical Pharmacology, 26, 177-181.
26. Reiter, R.J. (1998). Melatonin and human reproduction. Annals of Medicine, 30, 103-108.
27. Robertson, J.M., & Tanguay, P.E. (1997). Case study: the use of melatonin in a boy with refractory bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 822-825.
28. Shafii, M., MacMillan, D.R., Key, M.P., e.a. (1996). Nocturnal serum melatonin profile in major depression in children and adolescents. Archives of General Psychiatry, 53, 1009-1013.
29. Shochat, T., Haimov, I., & Lavie, P. (1998). Melatonin - the key to the gate of sleep. Annals of Medicine, 30, 109-114.
30. Smits, M.G., van Stel, H.F., van der Heijden, K., e.a. (2003). Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1286-1293.
31. Waldhauser, F., Ehrhart, B., & Förster, E. (1993). Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions. Experientia, 49, 671-681.
32. Wassmer, E., Quinn, E., Whitehouse, W., e.a. (2001). Melatonin as a sleep inductor for electroencephalogram recordings in children. Clinical Neurophysiology. Official Journal of the International Federation of Clinical Neurophysiology, 112, 683-685.
33. Waterman, G.S., Ryan, N.D., Perel J.M., e.a. (1992). Nocturnal urinary excretion of 6-hydroxymelatonin sulfate in prepubertal major depressive disorder. Biological Psychiatry, 31, 582-590.
34. Zhdanova, I.V., Lynch, H.J., & Wurtman, R.J. (1997). Melatonin: a sleep-promoting hormone. Sleep, 20, 899-907.